{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:44:17Z","timestamp":1784691857607,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.lungcan.2019.11.013","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T12:19:40Z","timestamp":1574079580000},"page":"124-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Detection of TGF-\u03b2 in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma"],"prefix":"10.1016","volume":"139","author":[{"given":"Paul","family":"Stockhammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Ploenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Theegarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-991X","authenticated-orcid":false,"given":"Clemens","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4341-4153","authenticated-orcid":false,"given":"Balazs","family":"Hegedus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2019.11.013_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/sonc.2002.30237","article-title":"The epidemiology of mesothelioma","volume":"29","author":"Britton","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s004080000075","article-title":"The pleura in health and disease","volume":"179","author":"Jones","year":"2001","journal-title":"Lung"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(90)90155-8","article-title":"TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights","volume":"63","author":"Moses","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1146\/annurev.cb.06.110190.003121","article-title":"The transforming growth factor-beta family","volume":"6","author":"Massague","year":"1990","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-beta signaling in Cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0035","first-page":"232","article-title":"Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection?","volume":"157","author":"Fontana","year":"1991","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021548","article-title":"Epithelial to mesenchymal transition by TGFbeta-1 induction increases stemness characteristics in primary non small cell lung cancer cell line","volume":"6","author":"Pirozzi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0045","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ijc.24188","article-title":"Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype","volume":"124","author":"Sodek","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0050","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1091\/mbc.e11-04-0306","article-title":"Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer","volume":"22","author":"Wendt","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0055","first-page":"10","article-title":"LY2157299 monohydrate, a TGF-betaR1 inhibitor, suppresses tumor growth and ascites development in ovarian Cancer","author":"Zhang","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0060","doi-asserted-by":"crossref","first-page":"98280","DOI":"10.18632\/oncotarget.21550","article-title":"Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma","volume":"8","author":"Yin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2016.04.018","article-title":"Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - a multi-institutional study","volume":"63","author":"Hoda","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0070","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.4161\/cc.21397","article-title":"Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFbeta signaling and defects in the Hippo signaling cascade","volume":"11","author":"Fujii","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20111653","article-title":"TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth","volume":"209","author":"Fujii","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/08977199409015049","article-title":"Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma","volume":"11","author":"Fitzpatrick","year":"1994","journal-title":"Growth Factors"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0085","first-page":"6180","article-title":"Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines","volume":"47","author":"Gerwin","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0090","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s004280000363","article-title":"Transforming growth factor beta production by spontaneous malignant mesothelioma cell lines derived from Fisher 344 rats","volume":"438","author":"Kuwahara","year":"2001","journal-title":"Virchows Arch."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0095","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/0008-5472.CAN-06-2389","article-title":"A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection","volume":"67","author":"Suzuki","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0100","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1158\/1078-0432.CCR-03-0611","article-title":"Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity","volume":"10","author":"Suzuki","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0105","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0110","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26218","article-title":"Immunological effects of the TGFbeta-blocking antibody GC1008 in malignant pleural mesothelioma patients","volume":"2","author":"Stevenson","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2249.1994.tb06144.x","article-title":"Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer","volume":"98","author":"Maeda","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4161\/cbt.4.3.1644","article-title":"Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma","volume":"4","author":"DeLong","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0125","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1378\/chest.118.6.1747","article-title":"Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions","volume":"118","author":"Cheng","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0130","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.rmed.2008.07.008","article-title":"Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions","volume":"102","author":"Duysinx","year":"2008","journal-title":"Respir. Med."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/resp.12874","article-title":"Malignant pleural fluid from mesothelioma has potent biological activities","volume":"22","author":"Cheah","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chest.2016.12.004","article-title":"Malignant mesothelioma biomarkers: from discovery to use in clinical practice for diagnosis, monitoring, screening, and treatment","volume":"152","author":"Creaney","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004145","article-title":"Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis","volume":"4","author":"Cui","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12943-017-0633-8","article-title":"Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells","volume":"16","author":"He","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0155","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgz103","article-title":"Biomarkers for malignant pleural mesothelioma: a meta-analysis","author":"Gillezeau","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0160","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability","volume":"31","author":"Yushkevich","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0165","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jtho.2016.09.123","article-title":"The IASLC mesothelioma staging project: improving staging of a rare disease through international participation","volume":"11","author":"Pass","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0170","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1183\/09031936.06.00135305","article-title":"Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses","volume":"27","author":"Hegmans","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0175","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jtho.2016.06.022","article-title":"Pleural effusions from patients with mesothelioma induce recruitment of monocytes and their differentiation into M2 macrophages","volume":"11","author":"Chene","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0180","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jtho.2016.07.019","article-title":"Modulating immunosuppression in the intrapleural space of malignant pleural mesothelioma and predictive biomarkers to guide treatment decisions","volume":"11","author":"Wong","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0185","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/JTO.0b013e3181f1903e","article-title":"Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population","volume":"5","author":"Flores","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0190","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/carcin\/bgy018","article-title":"FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase\/MMP1 signal","volume":"39","author":"Schelch","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ctrv.2015.05.001","article-title":"The established and future biomarkers of malignant pleural mesothelioma","volume":"41","author":"Panou","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0200","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.CCR-10-1929","article-title":"Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden","volume":"17","author":"Creaney","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.21037\/atm.2017.06.60","article-title":"Diagnosis and prognosis-review of biomarkers for mesothelioma","volume":"5","author":"Sun","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10549-007-9845-8","article-title":"Circulating transforming growth factor-beta-1 and breast cancer prognosis: results from the Shanghai Breast Cancer study","volume":"112","author":"Grau","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0215","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.3892\/mmr.2015.3250","article-title":"Prognostic significance of in situ and plasma levels of transforming growth factor beta1, -2 and -3 in cutaneous melanoma","volume":"11","author":"Tang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0220","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.5301\/jbm.5000229","article-title":"Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma","volume":"32","author":"Bonotti","year":"2017","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.lungcan.2019.11.013_bib0225","first-page":"7425","article-title":"Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology","volume":"34","author":"Franceschini","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0230","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/rccm.201203-0465PP","article-title":"Malignant pleural effusion: tumor-host interactions unleashed","volume":"186","author":"Stathopoulos","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lungcan.2019.11.013_bib0235","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the european respiratory society and the european society of thoracic surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur. Respir. J."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500219307275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500219307275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:36:22Z","timestamp":1759235782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500219307275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"alternative-id":["S0169500219307275"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2019.11.013","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of TGF-\u03b2 in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2019.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}